title: The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
authors.forename: Filip K
authors.initials: FK
authors.lastname: Knop
authors.forename: Tina
authors.initials: T
authors.lastname: Vilsbøll
authors.forename: Asger
authors.initials: A
authors.lastname: Lund
authors.forename: Thure
authors.initials: T
authors.lastname: Krarup
authors.forename: Jens J
authors.initials: JJ
authors.lastname: Holst
authors.forename: Mads
authors.initials: M
authors.lastname: Hornum
mesh_terms: D056947:Enzyme Replacement Therapy / Q000379:methods; D010188:Exocrine Pancreatic Insufficiency / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D052216:Glucagon-Like Peptide 1 / Q000097:blood / Q000378:metabolism; D053767:Glucagon-Like Peptide 2 / Q000097:blood / Q000378:metabolism*; D006801:Humans; D008297:Male; D010179:Pancreas / Q000201:enzymology; D050500:Pancreatitis, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D020799:Pancrelipase / Q000627:therapeutic use*; D019518:Postprandial Period / Q000187:drug effects
chemical_list: D005765:Gastrointestinal Agents; D053767:Glucagon-Like Peptide 2; D020799:Pancrelipase; D052216:Glucagon-Like Peptide 1